SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-021399
Filing Date
2024-05-08
Accepted
2024-05-08 08:59:38
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vcel-20240331.htm   iXBRL 10-Q 894744
2 EX-10.1 ex101vericelcorporation202.htm EX-10.1 30943
3 EX-31.1 ex311ceocertificationq12024.htm EX-31.1 13484
4 EX-31.2 ex312cfocertificationq12024.htm EX-31.2 11561
5 EX-32.1 ex321ceoandcfosoxcertifica.htm EX-32.1 9381
  Complete submission text file 0001628280-24-021399.txt   5356026

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20240331.xsd EX-101.SCH 34350
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcel-20240331_cal.xml EX-101.CAL 61882
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcel-20240331_def.xml EX-101.DEF 155901
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20240331_lab.xml EX-101.LAB 509113
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20240331_pre.xml EX-101.PRE 333358
69 EXTRACTED XBRL INSTANCE DOCUMENT vcel-20240331_htm.xml XML 740009
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35280 | Film No.: 24924446
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)